Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 4, Number 3—September 1998
THEME ISSUE
ICEID 1998
About Emerging Infectious Diseases

Health Policy Implications of Emerging Infections

Karen Hein
Author affiliation: Institute of Medicine, National Academy of Sciences, Washington, D.C., USA

Main Article

Figure 1

Estimated annual direct and indirect costs for selected sexually transmitted diseases (STDs) and their complications in 1994 versus national public investment in STD prevention and research in federal fiscal year 1995 (4).

Figure 1. Estimated annual direct and indirect costs for selected sexually transmitted diseases (STDs) and their complications in 1994 versus national public investment in STD prevention and research in federal fiscal year 1995 (4).

Main Article

References
  1. The  US. capacity to address tropical infectious disease problems. Washington: National Academy Press; 1987. p. 88. Sponsored by the Board on Science and Technology for International Development, Office of International Affairs, National Research Council and Institute of Medicine, National Academy of Sciences.
  2. The future of public health. Washington: National Academy Press; October 1988. p. 240. Sponsored by the Institute of Medicine, Division of Health Care Services.
  3. Lederberg  J, Shope  RE, Oaks  SC Jr, eds. Emerging infections: microbial threats to health in the United States. Washington: National Academy Press; October 1992. p. 312. Sponsored by the Institute of Medicine, Division of Health Sciences Policy and Division of International Health.
  4. Eng  TR, Butler  WT, eds. The hidden epidemic: confronting sexually transmitted diseases. Washington: National Academy Press; 1997. p. 392. Sponsored by the Institute of Medicine, Board on Health Promotion and Disease Prevention.
  5. Harrison  PF, Lederberg  J, eds. Orphans and incentives: developing technology to address emerging infections, Workshop Report. Washington: National Academy Press; 1997. Sponsored by the Institute of Medicine.
  6. Antimicrobial resistance: issues and options. Workshop Report. Washington: National Academy Press; 1998. Sponsored by the Institute of Medicine, Forum on Emerging Infections.
  7. America's vital interest in global health, protecting our people, enhancing our economy, and advancing our international interests. Washington: National Academy Press; 1997. Sponsored by the Institute of Medicine, Board on International Health.

Main Article

Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external